Karolien Goffin
Papers
1
Total Citations
6
H-Index
1
About
Karolien Goffin is a leading researcher in nuclear medicine and urological oncology, with a primary focus on advancing minimally invasive diagnostic and therapeutic techniques for prostate cancer. Her most impactful work centers on the development and clinical evaluation of innovative imaging tools, particularly the drop-in gamma probe for sentinel lymph node dissection. In her landmark multicentre clinical trial, Goffin demonstrated the feasibility and accuracy of this technology, enabling more precise, less invasive staging of prostate cancer—a contribution that has begun to reshape surgical protocols. While her citation count is still building, the 2023 trial has already garnered 6 citations, reflecting its immediate relevance to a field hungry for improved precision. Beyond this, Goffin’s research integrates hybrid imaging and targeted radiotracers, aiming to reduce overtreatment and enhance patient outcomes. Her work bridges the gap between nuclear medicine and urology, and she is recognized for her role in translating bench-to-bedside innovations. For students and researchers, Goffin exemplifies how a focused, clinically driven approach can yield tools that directly impact patient care, making her a rising authority in the intersection of imaging and surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1